In the past 2 months, we've had three instances of Baxter's Clearlink Continu-Flo Solution Set (2C8537) tubing spike drop out of Hospira's Heparin 25,000 units/250 ml (NDC 0409-4520-02) infusion bags. Reported to Hospira this AM. Any others with similar experience?

Hello, wondering if anyone has developed a clear step-wise process for the independent double check at their institution that they would be willing to share. I am looking to overhaul our institutions nursing education for independent double check and would like to better outline what our institution expectations are for steps completed during the process. Thanks in advance!

Good afternoon all,

For medication recall management, what proactive approaches do you currently have incorporated into the processes or procedures to ensure an effective response? For example, the ASHP Guidance for Medication Recalls provides guidelines but there is not a specific recommendation on how to directly address situations when a medication recall may cause a potential or temporary drug shortage concern.

Good afternoon all,

For medication recall management, what proactive approaches do you currently have incorporated into the processes or procedures to ensure an effective response? For example, the ASHP Guidance for Medication Recalls provides guidelines but there is not a specific recommendation on how to directly address situations when a medication recall may cause a potential or temporary drug shortage concern.

In pharmacies that draw up their own insulin, what syringe labeling system do you use? What is included on that label?

Thank you!

Good afternoon All,

Do any of your facilities use insulin for microneedling? What is your process for dispensing insulin? Do you allow dermatology to keep a vial in the clinic ADC to use as needed or do you have them enter an order per procedure and request it from the inpatient pharmacy?

For areas that have implemented barcode scanning in ambulatory scanning, are you including/requiring scanning related to procedural medications administered by providers? For example, we are finding that nursing is unable to complete the scanning process when providers administer injections and then the patient leaves. We are tempted to leave out these medications from our compliance monitoring but interested in how other sites have addressed this?

Hello!

Curious how others are dispensing medications that are NIOSH group 1, but listed within NIOSH table 2 - where known carcinogenicity - but teratogenicity / reproductive hazard. (specifically, curious on degarelix - which requires reconstitution, comes as a kit with required supplies; Eligard - packaged as two syringes)

Do nurses prepare these doses? (inpatient? clinics?)
PPE requirements?

Thanks in advance!
Emily

Good morning! We are writing a formal policy for BCMA for our facility and I was wondering if anyone has an example they are willing to share? While we want to outline the entire process, we want to focus in on the escalation process for scanning issues. Any guidance is much appropriated if you have a policy/process that works well. Thank you! Jordan

I am writing to see how folks are approaching the administration of premixed medications to pediatric patients for doses that result in volumes greater than 50 mL (so they cannot be infused on a syringe pump).